News & Updates
Filter by Specialty:
Mum’s infection during pregnancy may raise newborn’s risk of IBD
Exposure to any infection during early pregnancy or to a gastrointestinal infection during late pregnancy contributes to the increased likelihood of inflammatory bowel disease (IBD) development, especially Crohn’s disease, in the offspring, according to a study.
Mum’s infection during pregnancy may raise newborn’s risk of IBD
23 May 2024
Is exposure to antenatal corticosteroid harmful in the long run?
Antenatal exposure to corticosteroids, particularly betamethasone, does not increase the prevalence of cardiovascular risk factors or the incidence of major adverse cardiovascular events (MACE) up to 50 years of age, suggests a study.
Is exposure to antenatal corticosteroid harmful in the long run?
22 May 2024
Real-world data in Japan: 1L/2L palbociclib-ET effective in HR-positive/HER2-negative advanced breast cancer
Palbociclib combined with endocrine therapy (ET) is effective in hormone receptor (HR)–positive, HER2-negative advanced breast cancer (ABC) in both first-line (1L) and second-line (2L) settings in the real world, a multicentre observational study in Japan has shown.
Real-world data in Japan: 1L/2L palbociclib-ET effective in HR-positive/HER2-negative advanced breast cancer
13 May 2024
Dequalinium chloride works as well as metronidazole for bacterial vaginosis
In the treatment of bacterial vaginosis, dequalinium chloride is noninferior to metronidazole, with similarly high cure rates but better tolerability and fewer adverse events, according to a phase IV study.